-+ 0.00%
-+ 0.00%
-+ 0.00%

LifeSci Capital Initiates Coverage On Oculis Holding with Outperform Rating, Announces Price Target of $55

Benzinga·12/03/2025 13:55:03
Listen to the news
LifeSci Capital initiates coverage on Oculis Holding (NASDAQ:OCS) with a Outperform rating and announces Price Target of $55.